
Sign up to save your podcasts
Or
Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection.
5
11 ratings
Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection.
9,320 Listeners
111,084 Listeners
9,515 Listeners
6,899 Listeners
2 Listeners
17 Listeners
15,497 Listeners
10,622 Listeners